EGLN3 and central nervous system cancer: To determine if Egln3 could influence the kinetics of glioma development in vivo, we stereotaxically-engrafted Hu-glioma cells expressing Egln3 under the control of a Dox-inducible promoter into the cerebral cortex of immuno-compromised (NSG) mice.